OUR TEAM

Venkat is Founder and CEO of Karkinos Healthcare. He is currently engaged as an Advisor to the Chairman, Reliance Industries Limited, India's largest private sector company.
Prior to his association with Reliance, Venkat spent more than a decade and a half with the Tata Group in various capacities. His last assignment in the Tata Group was as Managing Trustee of the Tata Trusts wherein he was responsible for the operations, oversight and co-ordination between the various Tata Trusts.
In his role as the Chief Executive Officer of the Tata Trusts, Venkat was engaged in redefining the Tata Trusts' strategic approach with a view to making it relevant and responsive to the current needs of society while remaining within the mandate established by the Settlors. He was directly overseeing several large initiatives within the Trusts viz "Lakhpati Kisan – an program that aims to significantly enhance rural prosperity in under privileged and deprived communities, redefining Cancer Care across the country, technology enabled education initiatives in partnership with Massachusetts Institute of Technology (MIT) and the sanitation and nutrition projects in collaboration with Govt., of India.
He has over two decades of business and operations experience in the areas of finance, business support and strategy. From early 2007 to end 2012, he was Executive Assistant to Mr. Ratan N. Tata, the former Chairman of the Tata Group. During his stint in the Chairman's office of Tata Sons, Venkat was part of several significant projects including the Tata Motors acquisition of Jaguar Land Rover, launch of the small car Nano, creation of several Joint Ventures, responses in operating companies during the 2008 financial crisis etc., and was also privy to several senior leadership transitions and change management processes in the Tata Group. On behalf of the Chairman, he was the key point person to several entities in India and abroad.
Prior to his stint with Mr. Tata's office, Venkat was associated as Head of Business Support at the Qatar Foundation, a not for profit entity engaged in Education, Science and Community development based in Doha, wherein he played a key role in establishing partnerships with a number of leading US universities.
Venkat is a Science graduate and has done his MBA from the Sri Satya Sai University, Puttaparthi. He is also a Law Graduate from Mumbai University and has completed his Advanced Management Program (AMP) from the Harvard Business School. He is currently pursuing his EngD from the University of Warrick, UK on role of Technology in Health Care Systems.
Over the past several years, in his personal capacity, Venkat actively supported Mr. Ratan Tata in his investments in the technology, digital and e-commerce space that have now begun to attract significant attention in India and abroad. He was also the CEO of UC-RNT Fund, a US$ 350 million VC fund that Mr. Tata established in collaboration with the University of California. A key proponent of societal platforms, he is the midst of incubating alternative business and investment vehicles that work in the intersection of business, philanthropy, non-profits and governments on the notion of sustainable shared value creation for societal benefit
- Advisor to Chairman, Reliance Industries Ltd
- Chief of Staff to Chairman, Tata Sons and Managing Trustee of Tata Trusts
- Tata Memorial Hospital and Tata Medical Centre Trust, conceived Tata Centers for cancer care
- CEO and Partner of UC-RNT Fund and RNT Capital Advisors, a $350 million fund

Co-Founder, Medical Director and CEO, Karkinos Kerala
BSC, BDS, MB CHB, MD (USA), FDSRCS, FFDRCS, FRCS, FRCS ED, AB
Moni Abraham Kuriakose has previously served Narayana Health City, Bangalore as director of surgical oncology and director of Mazumdar Shaw Centre for Translational Research. Prior to this he had the following assignments-
- Chairman of Head and Neck Institute, Amrita Institute of Medical Sciences, Cochin,
- Attending Surgeon, and Professor, New York University,
- Professor and Vice Chairman Head and Neck Oncology and Director of Research, Roswell Park Cancer Institute, New York.
He is currently visiting professor at Roswell Park Cancer Institute and New York University. His clinical interests are management of advanced head and neck cancer, skull-base surgery, 3D planning and functional reconstruction. His research laboratory focus on understanding biology of oral cancer stem cells and targeting it to prevent oral cancer and using novel technology platform for early detection of the cancer. He has over 200 peer reviewed publications and five international patents to his credit. He is the author of a four-volume textbook titled `Contemporary Oral Oncology' and the Editor-in-Chief of the journal "Oral Cancer" by Springer-Nature group. He has served Indian head and neck cancer society (FHNO) as its past president and is the President Elect of International Academy of Oral Oncology (IAOO).
- Ex-Director, Surgical Oncology, Narayana Health City and ex-Director of Mazumdar Shaw centre for translational research
- Attending Surgeon and Professor at New York University; has 200 peer reviewed publications and 5 international patents
- Professor and Vice-Chairman, Head and Neck Oncology and Director of Research, Roswell Park Cancer Institute, New York
- President-elect of International Academy of Oral Oncology (IAOO) and Ex-President of Indian head and neck cancer society (FHNO)
Selected peer-reviewed publications
- P Mendonca, et al., Non-invasive imaging of oral potentially malignant and malignant lesions: A systematic review and meta-analysis, Oral Oncology 130, 105877, 2022.
- SJ Ma, H Yu, et al, Evaluation of Optimal Threshold of Neutrophil-Lymphocyte Ratio and Its Association With Survival Outcomes Among Patients With Head and Neck Cancer, JAMA Network Open 5 (4), e227567-e227567, 2022
- Iovoli AJ, et al. Among authors: Kuriakose MA. Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy. JAMA Network Open. 2020.
- Mehanna H, et al. Recommendations for head and neck surgical oncology practice in a setting of acute severe resource constraint during the COVID-19 pandemic: an international consensus. Lancet Oncol. 2020 Jun 11:S1470-2045(20)30334-X.
- Sivadasan P, et al. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection. J Proteomics. 2020 Feb 10;212:103574.
- Sumsum Sunny, et al. A smart tele-cytology point-of-care platform for oral cancer screening PLoS One. 2019; 14(11): e0224885
- Kulsum S, et al. Cancer stem cells and fibroblast niche cross talk in an in-vitro oral dysplasia model. Mol Carcinog. 2019 May;58(5):820-831. doi: 10.1002/mc.22974. Epub 2019 Jan 31.PMID: 30644602.
- Anurag K. Singh, et al. Combined surgery and radiation improves survival of tonsil squamous cell cancers. Oncotarget 08/2017; 8(68)
- Gangotri Siddappa, et al,. Curcumin and metformin mediated chemoprevention of oral cancer is associated with inhibition of cancer stem cells. Mol Carcinog 06/2017; 56(11)., DOI:10.1002/mc.22692
- Bhat AR, Gupta MK, Krithivasan P, Dhas K, Nair J, Reddy RB, Sudheendra HV, Chavan S, Vardhan H, Darsi S, Balakrishnan L, Katragadda S, Kekatpure V, Suresh A, Tata P, Panda B, Kuriakose MA, Sirdeshmukh R. Sample preparation method considerations for integrated transcriptomic and proteomic analysis of tumors Proteomics Clin Appl. 2017 Mar;11(3-4). doi: 10.1002/prca.201600100. Epub 2016. Nov 28. PMID: 27801551.

With close to two decades of experience working with the Tata Group, Sripriya has been a trusted strategic advisor and organizational transformation coach for many C-Suite leaders. She worked as Partner and Head for Organisation Change Management for Tata Consultancy Services, managing India, Asia Pacific, Australia and Middle East regions. She is a consistent high performer, recognised as one of the youngest partner and among top twenty five women high performers at Tata Consultancy Services. Sripriya is credited with leading more than fifty highly proficient change teams for large transformation initiatives in Asia Pacific and creating differentiated product offerings and consulting frameworks to manage large scale change in the areas of Next Generation solutions, Enterprise Agility, Digital, Cloud, Robotics and Machine Learning
Among her many successful transformation stories, Sripriya led a consulting team to help transform Wealth Management platform – integrating front to back office operations. Similarly, she helped modernise the IT platform for Department of Posts, India across 23 postal circles. Sripriya received her B.E. degree in Electronics and Communication from NMAM Institute of Technology and is a CTT certified consultant at Barett Values Centre on Leadership values assessment and culture
- Ex-Partner & Head for Organisational Change Management, Tata Consultancy Services (TCS), managing Asia+ region
- One of the youngest partners and was among the top 25 TCS women achievers in TCS Leadership Program
- Led over 50 large scale business initiatives across 14+ countries with clients such as JLR, UBS, GE Healthcare Financial Services, Petronas, Ericsson and more.
- Helped modernize the IT platform for Department of Posts, India across 23 postal circles impacting 500K+ employee base

